XML 38 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenues:        
Revenue from collaborative research $ 9,202 $ 11,838 $ 23,603 $ 21,905
Grant revenue 18 460 336 991
Total revenues 9,220 12,298 23,939 22,896
Costs and expenses:        
Research and development 17,335 11,049 31,904 21,146
General and administrative 4,145 1,503 7,403 5,336
Total costs and expenses 21,480 12,552 39,307 26,482
Loss from operations (12,260) (254) (15,368) (3,586)
Other income (expense) 1 (40) 1 (74)
Net comprehensive loss $ (12,259) $ (294) $ (15,367) $ (3,660)
Basic and diluted net loss per common share $ (0.44) $ (0.24) $ (0.57) $ (3.00)
Weighted average common shares outstanding, basic and diluted 27,651,297 1,219,884 26,960,664 1,184,507